Navigation Links
Chinese Biopharmaceutical Association Successfully Holds 15th Annual Conference
Date:6/25/2010

The Chinese Biopharmaceutical Association-USA (CBA) successfully held its 15th Annual Conference on June 12 -13 at USM Shady Grove Center, Rockville, Maryland. With the theme of Biopharmaceutical Medicines: Development and Commercialization without Borders, the two-day conference drew near 500 global attendees including research scientists, entrepreneurs, representatives from government agencies, and investors.

Potomac, Maryland (PRWEB) June 25, 2010 -- The Chinese Biopharmaceutical Association-USA (CBA) successfully held its 15th Annual Conference on June 12 -13 at USM Shady Grove Center, Rockville, Maryland.

With the theme of Biopharmaceutical Medicines: Development and Commercialization without Borders, the two-day conference drew near 500 global attendees including research scientists, entrepreneurs, representatives from government agencies, and investors.

More than 30 academia and industry leaders spoke at the conference. Five delegations from China’s leading biotech parks sponsored and presented at the conference, . including presentations from Mr. Guang-Yuan Liu, Mister of the Embassy of the People's Republic of China in the USA, and Mr. John P. McDonough, Secretary of the State of Maryland, attended the conference and delivered opening remarks.

Dr. Sujuan Ba, president of CBA president (2010-2011) and Chairperson of the cConference, presented the 2010 CBA Brilliant Achievement Award to Dr. Eric Green, director of the National Human Genome Research Institute, National Institutes of Health, and Mr. Gabriel Leung, president of Pharmaceuticals Business, OSI Pharmaceuticals.

The CBA Brilliant Achievement Award was established in 2003 to honor outstanding individuals who have made seminal contributions to science, technology, or business development in the biopharmaceutical fields; whose vision has moved medicine in new directions; and, who has been actively involved in building collaborative efforts internationally to advance medical fields.

The Award also aims to promote public awareness of the importance of collaborations between basic and applied researchers, between academia and industry, and between researchers and entrepreneurs.

Dr. Sujuan Ba also presented the 2010 CBA Outstanding Public Serviced Award to former CBA President (2004-2005) Dajun Yang, MD, PhD, President and CEO of Ascentage Pharma Group Corp., in reorganization of his long-lasting devotion to the growth of the CBA and his relentless efforts to help fulfill CBA’s mission of facilitating collaboration between biopharmaceutical professionals and promoting global business collaboration in biopharmaceutical fields.

At the end of the conference, Dr. Longzhi Feng was elected CBA’s new president-elect (2010-2011). According to CBA’s bylaw, Dr. Sujuan Ba automatically became CBA’s president and Dr. Yifan Zhai become CBA’s immediate-past president. He encourages every one of the CBA members to have a sense of ownership between the whole organization is “one body.”

About the Chinese Biopharmaceutical Association - USA

The Chinese Biopharmaceutical Association – USA (CBA) is one of the largest Chinese American professional associations in the United States. Founded in 1995, CBA is an independent, non-political, not for-profit professional organization dedicated to promoting science, technology, and business development in the biopharmaceutical fields by fostering research and business collaborations around the world. The Association is led by its elected board of directors and executive committee. For more information about the CBA and its programs, visit www.cba-usa.org.

###

Read the full story at http://www.prweb.com/releases/2010/06/prweb4189214.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. Chinese-American and Korean-American women at highest risk for diabetes in pregnancy
2. Luckey & Mullins Joins with Other National Construction Defect Law Firms to Form Chinese Drywall Legal Network
3. Urinary tract cancer associated with Chinese herbal products containing aristolochic acid
4. 2000th Free Cleft Lip/Palate Surgery Performed During Successful Chinese Mission
5. Chinese New Year Banquets Bring Good Luck, Happiness and Prosperity for the New Year
6. Tickerspy.com Announces New Stock Index Tracking Chinese Healthcare Stocks
7. Safety and diagnosis yield of colonoscopy in Hong Kong Chinese children
8. Springer Asia launches Chinese medicine textbook series in English
9. U.S. FDA Removes Many Chinese Candies From Import Alert 99-30 Based on Insufficient Evidence, According to FDAImports.com, LLC
10. Older Chinese consumers perceive themselves younger than actual age
11. Chinese systemic lupus erythematosus data reveal differences in epidemiology across continents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... (PRWEB) , ... February 17, 2017 , ... ... , drvallecillos.com , Beverly Hills plastic surgeon Dr. Glenn Vallecillos ... cells. , Dr. Vallecillos says, "Traditionally, plastic surgery has been centered around that ...
(Date:2/17/2017)... , ... February 17, 2017 , ... Smiles by Seese ... Center in Davidson, NC. Dr. Brian Seese leads the practice as a skilled and ... under one roof. Smiles by Seese serves patients of all ages with excellence in ...
(Date:2/17/2017)... ... February 17, 2017 , ... For the ... management solution to the exhibit floor for the 2017 HIMSS Conference & ... From Feb. 19–23, 2017, more than 40,000 healthcare industry professionals are expected at ...
(Date:2/17/2017)... ... 2017 , ... Qualis Health, one of the nation's leading ... DecisionHealth Platinum Awards in recognition of its innovative healthcare management programs that are ... award categories, highlighting four of the organization’s current programs:, , ...
(Date:2/17/2017)... ... February 17, 2017 , ... Pharmica Consulting attended CHI's ... facets of clinical trial planning and management. Pharmica discussed the importance of effective ... addition, attendees stopping by Pharmica’s booth were able to demo its cloud-based ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... , Feb. 17, 2017  Noble Capital Markets ... ESSA Pharma Inc. (Nasdaq: EPIX ). The ... Kumar Raja , PhD. ESSA Pharmaceuticals ... castration resistant prostate cancer (CRPC). Its lead compound EPI-506, ... the amino-terminal domain of the androgen receptor, thereby has ...
(Date:2/16/2017)... 16, 2017 Research and Markets has ... Medical Device Technologies" report to their offering. ... Traditional medical ... general instruments, non-drug coated implantables, large endoscopes, needle based drug ... over the last two to three decades for the treatment ...
(Date:2/16/2017)... DaVita Inc. (NYSE: DVA ) today announced results ... Net income attributable to DaVita Inc. for the ... or $0.80 per share and $880 million, or $4.29 per ... DaVita Inc. for the quarter and year ended December 31, ... or $0.98 per share, and $789 million, or $3.85 per ...
Breaking Medicine Technology: